Adam Drapczuk
Director of Finance/CFO at NEXGEL, INC.
Net worth: 165 649 $ as of 29/04/2024
Profile
Mr. Drapczuk has served as our Chief Financial Officer since June 1, 2021.
Mr. Drapczuk served as Financial Controller for R-Pharm US, a private fully integrated specialty pharmaceutical company focused on commercial opportunities to treat cancer and chronic immune diseases from September 2016 to April 2020 and has remained in a consulting role with the company since then.
He also served as Vice President of Finance, CFO, for Inpellis, Inc.; Controller and Director of Finance for Tris Pharma; and Director of Finance for West-Ward Pharmaceuticals Corp.
Mr. Drapczuk began his career in accounting and finance at KPMG LLP, servicing the firm’s assurance clients.
He received his B.S.
in accounting at Susquehanna University in Selinsgrove, PA and is a Certified Public Accountant.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
NEXGEL, INC.
1.16% | 28/04/2024 | 72,494 ( 1.16% ) | 165 649 $ | 29/04/2024 |
Adam Drapczuk active positions
| Companies | Position | Start |
|---|---|---|
| NEXGEL, INC. | Director of Finance/CFO | 31/05/2021 |
Former positions of Adam Drapczuk
| Companies | Position | End |
|---|---|---|
R-Pharm US LLC
 R-Pharm US LLC Pharmaceuticals: MajorHealth Technology R-Pharm US LLC engages in development and commercialization of medicines to treat cancer. Its products include IXEMPRA and episil. The company was founded by Mark Pavao and Demetrios Kydonieus in 2014 and is headquartered in Princeton, NJ. | Comptroller/Controller/Auditor | 31/03/2020 |
Inpellis, Inc.
 Inpellis, Inc. Pharmaceuticals: MajorHealth Technology Inpellis, Inc. operates as a specialty pharmaceutical company that focuses on developing and commercializing transdermal prescription therapeutics for treating acute and chronic pain resulting from musculoskeletal disorders and peripheral neuropathy. Its products include transdermal ibuprofen for moderate to severe osteoarthritis and transdermal benfotiamine for painful diabetic neuropathy. The company was founded in 2012 and is headquartered in Haddonfield, NJ. | Director of Finance/CFO | 31/03/2016 |
Tris Pharma, Inc.
 Tris Pharma, Inc. Pharmaceuticals: MajorHealth Technology Tris Pharma, Inc. engages in the provision of specialty pharmaceutical cervices. It focuses on the development of pharmaceutical science and technology-based products. The company was founded by Ketan Mehta in 2000 and is headquartered in Monmouth Junction, NJ. | Director of Finance/CFO | 31/01/2016 |
West-Ward Pharmaceutical Corp.
 West-Ward Pharmaceutical Corp. Pharmaceuticals: MajorHealth Technology West-Ward Pharmaceutical Corp. provides generic prescription medication services. It offers both oral solid and injectable pharmaceuticals to chain stores, wholesalers, distributors, health systems and government agencies. The company is headquartered in Eatontown, US. | Director of Finance/CFO | 30/06/2011 |
Training of Adam Drapczuk
| Susquehanna University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| NEXGEL, INC. | Process Industries |
| Private companies | 4 |
|---|---|
West-Ward Pharmaceutical Corp.
West-Ward Pharmaceutical Corp. Pharmaceuticals: MajorHealth Technology West-Ward Pharmaceutical Corp. provides generic prescription medication services. It offers both oral solid and injectable pharmaceuticals to chain stores, wholesalers, distributors, health systems and government agencies. The company is headquartered in Eatontown, US. | Health Technology |
Tris Pharma, Inc.
Tris Pharma, Inc. Pharmaceuticals: MajorHealth Technology Tris Pharma, Inc. engages in the provision of specialty pharmaceutical cervices. It focuses on the development of pharmaceutical science and technology-based products. The company was founded by Ketan Mehta in 2000 and is headquartered in Monmouth Junction, NJ. | Health Technology |
Inpellis, Inc.
Inpellis, Inc. Pharmaceuticals: MajorHealth Technology Inpellis, Inc. operates as a specialty pharmaceutical company that focuses on developing and commercializing transdermal prescription therapeutics for treating acute and chronic pain resulting from musculoskeletal disorders and peripheral neuropathy. Its products include transdermal ibuprofen for moderate to severe osteoarthritis and transdermal benfotiamine for painful diabetic neuropathy. The company was founded in 2012 and is headquartered in Haddonfield, NJ. | Health Technology |
R-Pharm US LLC
R-Pharm US LLC Pharmaceuticals: MajorHealth Technology R-Pharm US LLC engages in development and commercialization of medicines to treat cancer. Its products include IXEMPRA and episil. The company was founded by Mark Pavao and Demetrios Kydonieus in 2014 and is headquartered in Princeton, NJ. | Health Technology |
- Stock Market
- Insiders
- Adam Drapczuk
